Back to Top

New Hope for Chronic Iron Overload Patients as PAN Foundation Launches Co-Pay Assistance Program

 

Washington, D.C., December 6, 2013 – The Patient Access Network (PAN) Foundation is pleased to announce the launch of a financial assistance program designed to help patients being treated for chronic iron overload who are unable to afford the out-of-pocket costs associated with their treatment. The Foundation adds this co-pay assistance program to its more than 50 disease-specific programs aimed at reducing the financial burden of underinsured patients being treated with specialty medications.

"PAN is dedicated to assisting patient populations who need our help the most,” said Dr. Patrick McKercher, PAN President. “Chronic Iron Overload patients will now have streamlined access to their life-saving medications, allowing them to live more healthy and productive lives.”

Qualifying patients are eligible to receive up to $5,000, with the ability to apply for additional funds, per year to cover costs associated with their medications. Patients must have insurance that covers a part of their treatment, must have a household income less than or equal to 500% of the Federal Poverty Level and must reside and receive treatment in the United States.

About Chronic Iron Overload

Chronic Iron Overload, or hemochromatosis is an iron disorder where the body simply loads too much iron. Primary causes of this action are hereditary hemochromatosis, a genetic disorder, and transfusional iron overload, which can result from repeated blood transfusion. The causes can be distinguished between primary cases (hereditary or genetically determined) and less frequent secondary cases (acquired during life). People of Celtic (Irish, Scottish, Welsh, Cornish, Breton etc.), British, and Scandinavian origin have a particularly high incidence of hereditary hemochromatosis - of whom about 10% are carriers of the gene and 1% sufferers from the condition. Secondary hemochromatosis is often caused by multiple frequent blood transfusions (either whole blood or just red blood cells), which are usually needed either by individuals with hereditary anemias (such as beta-thalassemia major, sickle cell anemia, and Diamond–Blackfan anemia) or by older patients with severe acquired anemias such as in myelodysplastic syndromes.

About the PAN Foundation

Patient Access Network Foundation is dedicated to providing help and hope to patients who would otherwise be unable to afford high-cost specialty medications. PAN envisions a society in which every individual can access needed medical care, offering hope for a healthy tomorrow. PAN provides assistance through more than 50 disease-specific programs designed to help patients being treated for certain cancers, chronic illnesses, and rare diseases. Through our streamlined application process and state of the art online tools, we are able to ensure that patients are put on the fast track to therapy.